A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
Public ClinicalTrials.gov record NCT06177912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of V116 compared to PPSV23 in children and teenagers 2 through 17 years of age, who had completed routine pneumococcal vaccine as infants/toddlers. Researchers want to learn if V116 is as good as, or is better than the PPSV23 vaccine in terms of the antibody immune response. V116 and PPSV23 will be studied in children and teenagers who have a higher risk of getting pneumococcal disease (PD).
Study identification
- NCT ID
- NCT06177912
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 882 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 17, 2024
- Primary completion
- Feb 25, 2025
- Completion
- Feb 25, 2025
- Last update posted
- Mar 10, 2026
2024 – 2025
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates ( Site 0145) | Birmingham | Alabama | 35205 | — |
| Velocity Clinical Research, Phoenix ( Site 0122) | Phoenix | Arizona | 85006 | — |
| Madera Family Medical Group ( Site 0120) | Madera | California | 93637 | — |
| Optumcare Colorado Springs, LLC ( Site 0113) | Colorado Springs | Colorado | 80922 | — |
| Accel Research Sites Network- Nona Pediatric Center ( Site 0109) | Orlando | Florida | 32829 | — |
| University of South Florida-Department of Pediatrics ( Site 0110) | Tampa | Florida | 33606 | — |
| Velocity Clinical Research at Primary Pediatrics, Macon ( Site 0128) | Macon | Georgia | 31210 | — |
| Bingham Memorial Hospital ( Site 0149) | Blackfoot | Idaho | 83221 | — |
| Clinical Research Prime ( Site 0105) | Idaho Falls | Idaho | 83404 | — |
| Clinical Research Prime Rexburg ( Site 0104) | Rexburg | Idaho | 83440 | — |
| University of Louisville, Norton Children's Research Institute ( Site 0148) | Louisville | Kentucky | 40202 | — |
| Velocity Clinical Research, Lafayette ( Site 0103) | Lafayette | Louisiana | 70508 | — |
| Velocity Clinical Research, Gulfport ( Site 0115) | Gulfport | Mississippi | 39503 | — |
| Velocity Clinical Research, Hastings ( Site 0114) | Hastings | Nebraska | 68901 | — |
| Midwest Children's Health Research Institute ( Site 0117) | Lincoln | Nebraska | 68504 | — |
| Midwest Children's Health Research Institute ( Site 0106) | Lincoln | Nebraska | 68505 | — |
| Midwest Children's Health Research Institute-Research ( Site 0119) | Lincoln | Nebraska | 68516 | — |
| Midwest Children's Health Research Institute-Research ( Site 0102) | Lincoln | Nebraska | 68522 | — |
| Velocity Clinical Research, Albuquerque ( Site 0112) | Albuquerque | New Mexico | 87107 | — |
| Velocity Clinical Research, Vestal ( Site 0121) | Vestal | New York | 13850 | — |
| Epic Medical Research - Oklahoma ( Site 0134) | Chickasha | Oklahoma | 73018 | — |
| Tribe Clinical Research, LLC-Pediatrics ( Site 0118) | Greenville | South Carolina | 29607 | — |
| Tribe Clinical Research - Spartanburg ( Site 0108) | Spartanburg | South Carolina | 29301 | — |
| Velocity Clinical Research, Austin ( Site 0129) | Austin | Texas | 78759 | — |
| PanAmerican Clinical Research ( Site 0132) | Brownsville | Texas | 78521 | — |
| Epic Medical Research ( Site 0133) | DeSoto | Texas | 75115 | — |
| Epic Medical Research - Mesquite ( Site 0144) | Mesquite | Texas | 75150 | — |
| Alliance for Multispecialty Research, LLC ( Site 0140) | Layton | Utah | 84041 | — |
| Velocity Clinical Research, Salt Lake City ( Site 0124) | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06177912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06177912 live on ClinicalTrials.gov.